TY - JOUR
T1 - CTLA-4+ regulatory t cells increased in cetuximab-treated head and neck cancer patients suppress nk cell cytotoxicity and correlate with poor prognosis
AU - Jie, Hyun Bae
AU - Schuler, Patrick J.
AU - Lee, Steve C.
AU - Srivastava, Raghvendra M.
AU - Argiris, Athanassios
AU - Ferrone, Soldano
AU - Whiteside, Theresa L.
AU - Ferris, Robert L.
N1 - ©2015 American Association for Cancer Research.
PY - 2015/6/1
Y1 - 2015/6/1
KW - Cytotoxicity, Immunologic/genetics
KW - Prognosis
KW - T-Lymphocytes, Regulatory/drug effects
KW - Humans
KW - Middle Aged
KW - Male
KW - Gene Expression Regulation, Neoplastic/drug effects
KW - Apyrase/biosynthesis
KW - CTLA-4 Antigen/biosynthesis
KW - Antigens, CD/biosynthesis
KW - Antibodies, Monoclonal, Humanized/administration & dosage
KW - Forkhead Transcription Factors/biosynthesis
KW - Killer Cells, Natural/drug effects
KW - Transforming Growth Factor beta/biosynthesis
KW - Female
KW - Cetuximab
KW - Head and Neck Neoplasms/drug therapy
KW - Clinical Trials, Phase II as Topic
UR - https://www.scopus.com/pages/publications/84942170607
UR - https://www.scopus.com/pages/publications/84942170607#tab=citedBy
UR - https://www.mendeley.com/catalogue/54cb2f63-da0e-3951-aa9c-bc85b5d39e6f/
U2 - 10.1158/0008-5472.CAN-14-2788
DO - 10.1158/0008-5472.CAN-14-2788
M3 - Article
C2 - 25832655
AN - SCOPUS:84942170607
SN - 0008-5472
VL - 75
SP - 2200
EP - 2210
JO - Cancer Research
JF - Cancer Research
IS - 11
ER -